Global Coagulation Analyzer Market Research Report, Size, Business Opportunities, Growth, Industry Trend, Forecast 2025

This report aims to provide detailed insights into the global Coagulation Analyzer Market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Expected Revenue Growth: [155 Pages Report] The global coagulation analyzers market is projected to reach USD 5.0 billion by 2025 from USD 3.8 billion in 2020, at a CAGR of 5.7% between 2020 and 2025. Emerging economies such as India, China, and Brazil are expected to provide a wide range of opportunities for players in the industry. Furthermore, the increasing prevalence of cardiovascular diseases and blood disorders and the rising geriatric population are expected to boost the growth of this market in the coming years.

Download PDF Brochure:

Prothrombin time tests accounted for the largest market share in 2019

In 2019, the prothrombin time testing segment accounted for the largest share of the coagulation analyzers market. Growth in this market segment can be attributed to the high usage of prothrombin time tests in measuring the time it takes for blood to clot. These tests are used to monitor patients implanted with mechanical heart valves, ventricular assist devices, chronic atrial fibrillation, venous embolism and thrombosis of deep vessels of lower extremities, deep venous thrombosis, and pulmonary embolism.

Clinical laboratories segment dominated the coagulation analyzers market in 2019

On the basis of end user, the coagulation analyzers market is segmented into clinical laboratories, hospitals, and other end users. In 2019, the clinical laboratories segment accounted for the largest share of the coagulation analyzers market. This can be attributed to the large volume of coagulation testing being performed at these facilities.

Asia Pacific market to grow at the highest rate from 2020 to 2025

The coagulation analyzers market in the Asia Pacific is expected to grow at a high CAGR in the coming years. The factors contributing to the high growth of this market include the rising incidence/prevalence of blood-related disorders, increasing government initiatives for the improvement of healthcare infrastructure, rising number of general surgeries, and growth in research activities in several Asia Pacific countries. Moreover, the rapidly growing geriatric population (and the subsequent increase in the incidence of thalassemia, sickle-cell anemia, and leukemia) and healthcare infrastructure improvements in countries such as Japan, China, and Australia are expected to support the growth of this market in the coming years.

Request Sample Report:

Key Market Players

The major players operating in the coagulation analyzers market are Abbott Laboratories (US), Danaher (US), Siemens Healthineers Group (Germany), Sysmex Group (US), Thermo Fisher Scientific (US), Horiba (Japan), Nihon Kohden (Japan), Roche Diagnostics (Switzerland), Maccura Biotechnology Co. Ltd. (China), Bio Group Medical System (Italy), Genrui Biotech Inc. (China), A&T Corporation (Japan), Beijing Succeeder Technology Inc. (China), Diagnostica Stago SAS (France), Helena Laboratories (US), Hycel (Austria), Eurolyser (Austria), Bpc Biosed Srl (Italy), Robimes India Pvt. Ltd (India), Meril Life Sciences (India), ERBA Diagnostics, Inc. (US), Sclavo Diagnostics International S.r.l (Italy), Haematonics (US), Biosystems S.A. (Spain), and ACON (US).